Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Regular inhaled beta-agonist treatment in bronchial asthma.

Sears MR, Taylor DR, Print CG, Lake DC, Li QQ, Flannery EM, Yates DM, Lucas MK, Herbison GP.

Lancet. 1990 Dec 8;336(8728):1391-6.

PMID:
1978871
2.

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.

Taylor DR, Sears MR, Herbison GP, Flannery EM, Print CG, Lake DC, Yates DM, Lucas MK, Li Q.

Thorax. 1993 Feb;48(2):134-8.

3.

Increased inhaled bronchodilator vs increased inhaled corticosteroid in the control of moderate asthma.

Sears MR, Taylor DR, Print CG, Lake DC, Herbison GP, Flannery EM.

Chest. 1992 Dec;102(6):1709-15.

PMID:
1446477
4.

Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.

Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Taylor DR.

Respir Med. 2000 Aug;94(8):767-71.

5.

Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators.

van der Molen T, Postma DS, Turner MO, Jong BM, Malo JL, Chapman K, Grossman R, de Graaff CS, Riemersma RA, Sears MR.

Thorax. 1997 Jun;52(6):535-9.

6.
7.
8.

Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

Taylor DR, Town GI, Herbison GP, Boothman-Burrell D, Flannery EM, Hancox B, Harré E, Laubscher K, Linscott V, Ramsay CM, Richards G.

Thorax. 1998 Sep;53(9):744-52. Erratum in: Thorax 1999 Feb;54(2):188.

9.

Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.

Rosenthal RR, Busse WW, Kemp JP, Baker JW, Kalberg C, Emmett A, Rickard KA.

Chest. 1999 Sep;116(3):595-602.

PMID:
10492259
11.

Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.

Aziz I, Hall IP, McFarlane LC, Lipworth BJ.

J Allergy Clin Immunol. 1998 Mar;101(3):337-41.

PMID:
9525449
12.

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.

D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI.

JAMA. 1994 May 11;271(18):1412-6.

PMID:
7909853
13.

Randomised placebo controlled trial of beta agonist dose reduction in asthma.

Harrison TW, Oborne J, Wilding PJ, Tattersfield AE.

Thorax. 1999 Feb;54(2):98-102.

14.

Proof-of-concept evaluation of trough airway hyper-responsiveness following regular racemic or levosalbutamol in genotype-stratified steroid-treated persistent asthmatic patients.

Anderson WJ, Short PM, Williamson PA, Morrison AE, Palmer C, Tavendale R, Lipworth BJ.

Clin Sci (Lond). 2014 Jan 1;126(1):75-83. doi: 10.1042/CS20130213.

PMID:
23829494
15.
16.

Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study.

Wilding P, Clark M, Thompson Coon J, Lewis S, Rushton L, Bennett J, Oborne J, Cooper S, Tattersfield AE.

BMJ. 1997 May 17;314(7092):1441-6.

17.

Once-daily tiotropium Respimat(®) 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma.

Timmer W, Moroni-Zentgraf P, Cornelissen P, Unseld A, Pizzichini E, Buhl R.

Respir Med. 2015 Mar;109(3):329-38. doi: 10.1016/j.rmed.2014.12.005. Epub 2014 Dec 27.

18.

Comparison of the effects of salmeterol and formoterol in patients with severe asthma.

Nightingale JA, Rogers DF, Barnes PJ.

Chest. 2002 May;121(5):1401-6.

PMID:
12006420
19.
20.

Effects of treatment with formoterol on bronchoprotection against methacholine.

Lipworth B, Tan S, Devlin M, Aiken T, Baker R, Hendrick D.

Am J Med. 1998 May;104(5):431-8.

PMID:
9626025

Supplemental Content

Support Center